BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3658Biotechnology
$7.28 +$0.00 (0.00%)
Pre-market · Oct 8, 8:20 am ET · After hours $7.30 +0.28%
Open$7.27
Prev close$7.28
Day range$7.18 – $7.31
Volume833.1K
Market cap$567.43M
P/E (TTM)3.3
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings3.3x
CheapRich

Above its usual level · 75th percentile, 5-year average -0.9x

#138 of 2972 stocks by PE (1 = cheapest)

Price / book1.2x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 4.1x

#1738 of 5317 stocks by PB (1 = cheapest)

Price / sales1.2x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 2,114.5x

#1857 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-38x-3x32x67xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$11.18
Price vs. fair value-34.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.23 – 4.08 0% (cheaper than usual) #1738 of 5317 (1 = cheapest)
PE 3.34 -25.45 -0.89 75% (pricier than usual) #138 of 2972 (1 = cheapest)
PS 1.24 2.30 2,114.45 0% (cheaper than usual) #1857 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$11.18
Economic moatNone
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on CRMD.

Leave a comment

Scroll to Top